Microbial Contamination Prompts Recall of Robitussin Honey Cough Syrup

25 Jan 2024
www.drugs.com
THURSDAY, Jan. 25, 2024 -- Eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult cough syrups have been recalled due to possible contamination.
The products, which are made by Haleon, may be contaminated with a microbe, and "in immunocompromised individuals, the use of the affected product could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection," the recall notice said.
In people with healthy immune systems, infection is unlikely to lead to severe illness. "However, the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out," the company said.
Haleon says that no illnesses in customers using the product have yet been reported.
The recall only pertains to eight specific lots, which are listed in the full company announcement posted by the U.S. Food and Drug Administration.
Customers who know they have purchased one of the recalled products should not use them, and they should reach out to Haleon at 1-800-245-1040 (Monday through Friday 8 a.m. to 6 p.m. Eastern Time) or via email to mystory.us@haleon.com.
More Information
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.